Resources from the same session
MOUNTAINEER: Open-label, phase 2 study of tucatinib in combination with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017)
Presenter: Jonathan Strickler, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Rare Genomic Alterations Including Mutations and Fusions and Discussant
Presenter: Heinz-Josef Lenz, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides